Mark D Stewart (Mark Stewart)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Electronic Health Record

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO clinical cancer informatics

Therapeutic innovation & regulatory science

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Grace Collins, Hillary S Andrews, Brittany Avin McKelvey, Carrigan Rice, Jeff D Allen, Mark D Stewart
An Evaluation of Novel Oncology Approvals with a PMR/C for Assessing Data in Racial and Ethnic Populations Underrepresented in Premarket Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Grace Collins, Hillary S Andrews, Brittany Avin McKelvey, Carrigan Rice, Jeff D Allen, Mark D Stewart
An Evaluation of Novel Oncology Approvals with a PMR/C for Assessing Data in Racial and Ethnic Populations Underrepresented in Premarket Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Brittany Avin McKelvey, Elizabeth Garrett-Mayer, Donna R Rivera, Amy Alabaster, Hillary S Andrews, Elizabeth G Bond, Thomas D Brown, Amanda Bruno, Lauren Damato, Janet L Espirito, Laura L Fernandes, Eric Hansen, Paul Kluetz, Xinran Ma, Andrea McCracken, Pallavi S Mishra-Kalyani, Yanina Natanzon, Danielle Potter, Nicholas J Robert, Lawrence Schwartz, Regina Schwind, Connor Sweetnam, Joseph Wagner, Mark D Stewart, Jeff D Allen
Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Chemotherapy. JCO clinical cancer informatics 8 (2024)
Grace Collins, Hillary S Andrews, Brittany Avin McKelvey, Carrigan Rice, Jeff D Allen, Mark D Stewart
An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Grace Collins, Hillary S Andrews, Brittany Avin McKelvey, Carrigan Rice, Jeff D Allen, Mark D Stewart
An Evaluation of Novel Oncology Approvals with a PMR/C for Assessing Data in Racial and Ethnic Populations Underrepresented in Premarket Clinical Trials. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Christina A Clarke, Breeana L Mitchell, Girish Putcha, Emma Alme, Peter Bach, Jonathan P Beer, Tomasz M Beer, Michelle A Beidelschies, Jody Hoyos, Eric Klein, Peter Kuhn, Nancy Krunic, Kathryn Lang, Jerry S H Lee, Dorys Lopez Ramos, David Morgenstern, Elissa Quinn, Victoria M Raymond, Wendy S Rubinstein, Stephanie A Sanchez, Ryan Serra, Mark D Stewart, Lauren C Leiman
Lexicon for blood-based early detection and screening: BLOODPAC consensus document. Clinical and translational science 17 (9) (2024)
Christina M Lockwood, Jason D Merker, Elizabeth Bain, Caroline Compton, Robert L Grossman, Donald Johann, Frederick S Jones, Gregory Jones, Matthew Kreifels, Suzanne LeBlang, Jerry S H Lee, John Lyle, Jean-Francois Martini, Lauren Saunders, Howard I Scher, Stella B Somiari, Mark D Stewart, Jacob Vinson, Lauren C Leiman
Towards Preanalytical Best Practices for Liquid Biopsy Studies: A BLOODPAC Landscape Analysis. Clinical pharmacology and therapeutics (2024)
Brittany Avin McKelvey, Alexandra Berk, Lynda Chin, Stacie Hudgens, Ian Kudel, Ronan C O'Hagan, Amila Patel, Julie Scott, Hillary S Andrews, Sam Wang, Debra Wujcik, Mark D Stewart, Jeff D Allen
A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets. JCO clinical cancer informatics 7 (2023)
Brittany Avin McKelvey, Alexandra Berk, Lynda Chin, Stacie Hudgens, Ian Kudel, Ronan C O'Hagan, Amila Patel, Julie Scott, Hillary S Andrews, Sam Wang, Debra Wujcik, Mark D Stewart, Jeff D Allen
A Study Design to Harmonize Patient-Reported Outcomes Across Data Sets. JCO clinical cancer informatics 7 (2023)
Grace Collins, Brittany Avin McKelvey, Hillary S Andrews, Jeff D Allen, Mark D Stewart
An Analysis of Dosing-Related Postmarketing Requirements for Novel Oncology Drugs Approved by the U.S. Food and Drug Administration, 2012-2022. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Joseph M Unger, Hillary S Andrews, Laura A Levit, Mark D Stewart, Brittany Avin McKelvey, Beverly E Canin, Emily Dressler, Keith T Flaherty, Peter Fredette, Lee Jones, Peggy McCann, Therica M Miller, Adedayo A Onitilo, Fran Palmieri, Timil Patel, Rocio Paul, Gary L Smith, Suanna Steeby Bruinooge, Elizabeth Garrett-Mayer, Xiudong Jennifer Lei, Ajjai Alva, Caroline Schenkel
Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality. JCO oncology practice (2023)
Grace Collins, Mark D Stewart, Brittany Avin McKelvey, Hillary Stires, Jeff D Allen
Breakthrough Therapy Designation Criteria Identify Drugs that Improve Clinical Outcomes for Patients: A Case for More Streamlined Coverage of Promising Therapies. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Daniel F Hayes, Roy S Herbst, Jonathan L Myles, Suzanne L Topalian, Sophia L Yohe, Naomi Aronson, Andrew M Bellizzi, Upal Basu Roy, Georganne Bradshaw, Robin H Edwards, Ehab A El-Gabry, Julia A Elvin, Thomas F Gajewski, Lisa Meier McShane, Matthew Oberley, Reena Philip, David L Rimm, Jason N Rosenbaum, Eric H Rubin, Lisa Schlager, Shimere W Sherwood, Mark D Stewart, Janis M Taube, Magdalena Thurin, Patricia Vasalos, Jordan Laser
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit. JCO precision oncology 6 (2022)
Diana Merino Vega, Katherine K Nishimura, Névine Zariffa, Jeffrey C Thompson, Antje Hoering, Vanessa Cilento, Adam Rosenthal, Valsamo Anagnostou, Jonathan Baden, Julia A Beaver, Aadel A Chaudhuri, Darya Chudova, Alexander D Fine, Joseph Fiore, Rachel Hodge, Darren Hodgson, Nathan Hunkapiller, Daniel M Klass, Julie Kobie, Carol Peña, Gene A Pennello, Neil Peterman, Reena Philip, Katie J Quinn, David Raben, Gary L Rosner, Mark Sausen, Ayse Tezcan, Qi Xia, Jing Yi, Amanda G Young, Mark D Stewart, Erica L Carpenter, Charu Aggarwal, Jeff D Allen
Changes in Circulating Tumor DNA Reflect Clinical Benefit Across Multiple Studies of Patients With Non-Small-Cell Lung Cancer Treated With Immune Checkpoint Inhibitors. JCO precision oncology 6 (2022)
Mark D Stewart, Diana Merino Vega, Rebecca C Arend, Jonathan F Baden, Olena Barbash, Nike Beaubier, Grace Collins, Tim French, Negar Ghahramani, Patsy Hinson, Petar Jelinic, Matthew J Marton, Kimberly McGregor, Jerod Parsons, Lakshman Ramamurthy, Mark Sausen, Ethan S Sokol, Albrecht Stenzinger, Hillary S Andrews, Kirsten M Timms, Diana Turco, Iris Wang, J Andrew Williams, Elaine Wong-Ho, Jeff Allen
Homologous Recombination Deficiency: Concepts, Definitions, and Assays. The oncologist 27 (3) (2022)
David Merola, Ulka Campbell, Nileesa Gautam, Alexa Rubens, Sebastian G Schneeweiss, Shirley V Wang, Gillis Carrigan, Victoria Chia, Osayi E Akinbosoye, Simone Pinheiro, Amanda Bruno, Xiaolong Jiao, Mark D Stewart, Rachele Hendricks-Sturrup, Carla Rodriguez-Watson, Sajan Khosla, Yiduo Zhang, Mothaffar Rimawi, Jenny Huang, Aliki Taylor, Lauren Becnel, Lynn McRoy, Joy Eckert, Benjamin Taylor
The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology. Clinical pharmacology and therapeutics (2022)
Pia Horvat, Christen M Gray, Alexandrina Lambova, Jennifer B Christian, Laura Lasiter, Mark D Stewart, Jeff D Allen, Paul Clarke, Cong Chen, Adam Reich
Comparing Findings From a Friends of Cancer Research Exploratory Analysis of Real-World End Points With the Cancer Analysis System in England. JCO clinical cancer informatics 5 (2022)
Christina A Clarke, Kathryn Lang, Girish Putcha, Jonathan P Beer, Maude Champagne, Andrea Ferris, James H Godsey, Robert L Grossman, Jody M Hoyos, Donald J Johann, Nancy Krunic, Peter Kuhn, Jerry S H Lee, Tara Maddala, Marielena Mata, Jeremiah McDole, Omar Perez, Howard Scher, Mark D Stewart, Seema Singh Bhan, Qu Zhang, Lauren C Leiman
BLOODPAC: Collaborating to chart a path towards blood-based screening for early cancer detection. Clinical and translational science (2022)
Xiang Yin, Pallavi S Mishra-Kalyan, Rajeshwari Sridhara, Mark D Stewart, Elizabeth A Stuart, Ruthanna C Davi
Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer. Journal of biopharmaceutical statistics 32 (1) (2022)
Alexander I Spira, Mark D Stewart, Suzanne F Jones, Elaine Chang, Anitra Fielding, Nicole Richie, Laura S Wood, Michael A Thompson, Abhilasha Nair, Brandon A Mahal, David E Gerber
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Edward S Kim, Thomas S Uldrick, Caroline Schenkel, Suanna Steeby Bruinooge, Robert Donald Harvey, Allison Magnuson, Alexander Spira, James L Wade, Mark D Stewart, Diana Merino Vega, Julia A Beaver, Andrea M Denicoff, Gwynn Ison, S Percy Ivy, Suzanne George, Raymond P Perez, Patricia A Spears, William D Tap, Richard L Schilsky
Continuing to Broaden Eligibility Criteria to Make Clinical Trials More Representative and Inclusive: ASCO-Friends of Cancer Research Joint Research Statement. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
Grace Collins, Mark D Stewart, Ellen Sigal, Jeff Allen
Expedited Development Programs at the Food and Drug Administration: Insights and Opportunities. Therapeutic innovation & regulatory science 55 (3) (2021)
Michael Shea, Céline Audibert, Mark D Stewart, Brittany Gentile, Diana Merino, Agnes Hong, Laura Lassiter, Alexis Caze, Jonathan Leff, Jeff Allen, Ellen Sigal
How Oncologists Perceive the Availability and Quality of Information Generated From Patient-Reported Outcomes (PROs). Journal of patient experience 7 (2) (2019)
Tahira Khan, Mark D Stewart, Samuel Blackman, Raphaël Rousseau, Martha Donoghue, Kenneth Cohen, Nita Seibel, Mark Fleury, Bouchra Benettaib, Raleigh Malik, Gilles Vassal, Gregory Reaman
Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols. Therapeutic innovation & regulatory science 53 (2) (2018)
Michael B Shea, Mark D Stewart, Hugo Van Dyke, Linda Ostermann, Jeff Allen, Ellen Sigal
Outdated Prescription Drug Labeling: How FDA-Approved Prescribing Information Lags Behind Real-World Clinical Practice. Therapeutic innovation & regulatory science 52 (6) (2018)